Published in Pharmacol Ther on January 01, 1983
In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest (1992) 2.04
Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest (1996) 1.98
A mycobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic. J Exp Med (1990) 1.75
Anti-arthritic potential of the plant Justicia gendarussa Burm F. Clinics (Sao Paulo) (2009) 1.09
Studies of eicosanoid production in the air pouch model of synovial inflammation. Agents Actions (1986) 1.06
Lymphoid abnormalities in rats with adjuvant-induced arthritis. I. Mitogen responsiveness and lymphokine synthesis. Ann Rheum Dis (1984) 1.03
Effect of iron chelation on inflammatory joint disease. Ann Rheum Dis (1987) 1.03
Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. Br J Pharmacol (2005) 0.99
Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. J Exp Med (1995) 0.99
Anti-inflammatory activity of emu oils in rats. Inflammopharmacology (1997) 0.99
The comparative study of Sprague-Dawley and Lewis rats in adjuvant-induced arthritis. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.94
Expression of cytokine mRNA and protein in joints and lymphoid organs during the course of rat antigen-induced arthritis. Arthritis Res Ther (2005) 0.91
Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibody. Clin Exp Immunol (1989) 0.90
Role of TNF alpha in the induction of antigen induced arthritis in the rabbit and the anti-arthritic effect of species specific TNF alpha neutralising monoclonal antibodies. Ann Rheum Dis (1995) 0.89
Effect of peroxisome proliferator-activated receptor gamma agonist (pioglitazone) and methotrexate on disease activity in rheumatoid arthritis (experimental and clinical study). Clin Med Insights Arthritis Musculoskelet Disord (2011) 0.87
A modified mouse air pouch model for evaluating the effects of compounds on granuloma induced cartilage degradation. Br J Pharmacol (1988) 0.84
The immune response to pertussis in the 6-day air pouch: a model of chronic synovitis. Br J Exp Pathol (1985) 0.84
Lupeol, a triterpenoid isolated from Calotropis gigantea latex ameliorates the primary and secondary complications of FCA induced adjuvant disease in experimental rats. Inflammopharmacology (2011) 0.83
Over the counter (OTC) oral remedies for arthritis and rheumatism: how effective are they? Inflammopharmacology (1999) 0.82
International experience with etodolac therapy for rheumatoid arthritis: an interim report of comparative efficacy. Clin Rheumatol (1989) 0.82
Calcineurin inhibitors exert rapid reduction of inflammatory pain in rat adjuvant-induced arthritis. Br J Pharmacol (2003) 0.81
Protective effects of indomethacin and cyclophosphamide but not of infliximab on liver metabolic changes caused by adjuvant-induced arthritis. Inflammation (2011) 0.79
The effect of FK506 and cyclosporin A on antigen-induced arthritis. Clin Exp Immunol (1991) 0.77
Ameliorative Effects of a Polyphenolic Fraction of Cinnamomum zeylanicum L. Bark in Animal Models of Inflammation and Arthritis. Sci Pharm (2013) 0.77
Modulation of alpha 1-acid glycoprotein (AGP) gene induction following honey bee venom administration to adjuvant arthritic (AA) rats; possible role of AGP on AA development. Clin Exp Immunol (1993) 0.77
Acute phase protein changes in antigen-induced mono-articular arthritis in rabbits and mice. Clin Exp Immunol (1986) 0.77
Anti-inflammatory effect of Acacia visco extracts in animal models. Inflammopharmacology (2010) 0.76
The influence of anti-rheumatic drugs on hepatic mRNA levels of acute-phase proteins in rats with adjuvant arthritis. Agents Actions (1993) 0.76
Parasitic infection as a potential therapeutic tool against rheumatoid arthritis. Exp Ther Med (2016) 0.75
Inhibitory effect of sodium aurothiomalate on a chronic inflammatory model in the rat. Ann Rheum Dis (1985) 0.75
Phenotypic characterization of type II collagen-induced arthritis in Wistar rats. Exp Ther Med (2015) 0.75
A time course study of the changes that occur to the subcutaneous model of synovium following polyarthritogen. Br J Exp Pathol (1987) 0.75
Effect of Santolina oblongifolia on ACII-immunized animals. Inflammopharmacology (1997) 0.75
Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med (1982) 6.79
A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med (1995) 6.14
Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol (1987) 5.33
Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med (1982) 4.40
Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep (1978) 2.63
Some recent advances in cardiac pathology. Hum Pathol (1979) 2.17
Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol (1980) 2.17
Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest (1992) 2.07
Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum (2000) 2.01
Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest (1984) 1.91
Diagnosis of human cardiac allograft rejection by serial cardiac biopsy. J Thorac Cardiovasc Surg (1973) 1.82
Transesophageal echocardiography and its potential for esophageal damage. Anesthesiology (1990) 1.80
Cardiac transplant atherosclerosis. Transplant Proc (1987) 1.74
Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep (1978) 1.68
Early anthracycline cardiotoxicity. Am J Med (1978) 1.63
Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci U S A (1990) 1.59
Endocardial infiltrates in human heart transplants: a serial biopsy analysis comparing four immunosuppression protocols. Hum Pathol (1990) 1.50
Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies. J Thorac Cardiovasc Surg (1989) 1.49
Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease. Lancet (1991) 1.49
Graft vascular disease in the great vessels and vasa vasorum. Hum Pathol (1993) 1.41
In situ hybridization studies for viral nucleic acids in heart and lung allograft biopsies. Am J Clin Pathol (1990) 1.41
Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis. Biochem J (1980) 1.40
Echocardiographic recognition and implications of ventricular hypertrophic trabeculations and aberrant bands. Circulation (1984) 1.36
Whipple's disease presenting as aortic insufficiency. N Engl J Med (1981) 1.36
Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med (1978) 1.34
The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant (1989) 1.34
Percutaneous transvenous endomyocardial biopsy. JAMA (1973) 1.33
Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. Circulation (1987) 1.28
Cardiac sarcoidosis: response to steroids and transplantation. J Heart Transplant (1987) 1.26
Leukocytic infiltrates in idiopathic dilated cardiomyopathy. A source of confusion with active myocarditis. Am J Surg Pathol (1986) 1.24
Letter: An anti-inflammatory peptide from bee venom. Nature (1973) 1.23
In vivo and in vitro stimulation of chondrocyte biosynthetic activity in early experimental osteoarthritis. Arthritis Rheum (1984) 1.23
Myocardial contraction bands revisited. Hum Pathol (1986) 1.22
Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels. Transplantation (1993) 1.22
Quantitative pharmacologic responses of normal and atherosclerotic isolated human epicardial coronary arteries. Circulation (1984) 1.21
Cytokines as inflammatory mediators. Br Med Bull (1987) 1.20
Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy. Ann Intern Med (1983) 1.19
Isolated pulmonary rejection after combined heart-lung transplantation. J Thorac Cardiovasc Surg (1985) 1.19
Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol. Am Heart J (1983) 1.19
The role of the acute phase reaction in inflammation. Agents Actions (1976) 1.18
Demonstration of increased proteoglycan turnover in cartilage explants from dogs with experimental osteoarthritis. J Orthop Res (1984) 1.16
Pathologic pulmonary alterations in long-term human heart-lung transplantation. Hum Pathol (1985) 1.14
Altered orientation of glycosaminoglycans and cellular changes in the tibial cartilage in the first two weeks of experimental canine osteoarthritis. J Orthop Res (1985) 1.13
Calcific deposits in porcine bioprostheses: structure and pathogenesis. Am J Cardiol (1980) 1.13
Partial purification of the anti-inflammatory factor(s) in inflammatory exudate. Br J Pharmacol (1969) 1.12
Structural changes in glutaraldehyde-treated porcine heterografts used as substitute cardiac valves. Transmission and scanning electron microscopic observations in 12 patients. Am J Cardiol (1978) 1.12
Animal models of degenerative joint disease. Curr Top Pathol (1982) 1.11
Detection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction. Am J Pathol (1991) 1.11
Echocardiographic recognition of paraseptal structures. J Am Coll Cardiol (1985) 1.10
Adriamycin cardiotoxicity: endomyocardial biopsy evidence of enhancement by irradiation. Am J Surg Pathol (1977) 1.10
Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy. Cancer Treat Rep (1978) 1.10
Acute and chronic cardiovascular effects of doxorubicin in the dog: the cardiovascular pharmacology of drug-induced histamine release. J Cardiovasc Pharmacol (1980) 1.09
Thromboembolic complications with the indwelling balloon-tipped pulmonary arterial catheter. N Engl J Med (1974) 1.08
Serial transvenous biopsy of the transplanted human heart. Improved management of acute rejection episodes. Lancet (1974) 1.07
Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity. Am Heart J (1983) 1.07
Rheumatoid arthritis: effects of a new agent (ICI 55 897) on serum acute phase proteins and the erythrocyte sedimentation rate. Ann Rheum Dis (1980) 1.07
Acute myocardial infarction in cardiac transplant recipients. Am J Cardiol (1989) 1.05
Efficacy and cost of cardiac monitoring in patients receiving doxorubicin. Cancer (1982) 1.04
Distant heart procurement for human transplantation. Ultrastructural studies. Circulation (1980) 1.04
A 71-kD heat shock protein (hsp) from Mycobacterium tuberculosis has modulatory effects on experimental rat arthritis. Clin Exp Immunol (1996) 1.04
Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. Am Heart J (1981) 1.04
Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Transplantation (1990) 1.03
2 anti-inflammatory components in antilymphocytic serum. Nature (1970) 1.03
Diagnosis and treatment of allograft rejection in heart-lung transplant recipients. J Thorac Cardiovasc Surg (1983) 1.03
Long-term results, hemodynamics, and complications after combined heart and lung transplantation. Circulation (1985) 1.03
Ultrastructural changes in articular cartilage after experimental section of the anterior cruciate ligament of the dog knee. J Anat (1983) 1.02
Enzymic heterogeneity of normal canine articular cartilage. Cell Biochem Funct (1986) 1.01
Cocaine and the heart. Hum Pathol (1987) 1.01
Cardiomyopathy in a rat model of pheochromocytoma. Morphological and functional alterations. Am J Cardiovasc Pathol (1988) 1.01
The morphological progression of viral myocarditis. Postgrad Med J (1986) 1.00
Endomyocardial biopsy detection of acute rejection in cardiac allograft recipients. Heart Vessels Suppl (1985) 1.00
The International Society for Heart and Lung Transplantation grading system for heart transplant biopsy specimens: clarification and commentary. J Heart Lung Transplant (1998) 1.00
Elevated synovial fluid levels of interleukin-6 and tumor necrosis factor associated with early experimental canine osteoarthritis. Arthritis Rheum (1993) 1.00
Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteries of cholesterol-fed rabbits. Lab Invest (1983) 0.99
Structure of newly synthesised (35S)-proteoglycans and (35S)-proteoglycan turnover products of cartilage explant cultures from dogs with experimental osteoarthritis. J Orthop Res (1985) 0.98
Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals. JAMA (1978) 0.98
The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplant (1993) 0.98
Influence of hypoxia in inflammatory synovitis. Ann Rheum Dis (1998) 0.98
The status of cardiac transplantation, 1975. Circulation (1975) 0.97
Intravascular ultrasound imaging of coronary arteries. Is three layers the norm? Circulation (1992) 0.97
Anthracycline-associated cardiac and renal damage in rabbits. Evidence for mediation by vasoactive substances. Lab Invest (1981) 0.96
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation (1995) 0.96
Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol (1994) 0.96
The glycosaminoglycans in menisci in experimental and natural osteoarthritis. Arthritis Rheum (1983) 0.96
Airway pathology in the transplanted rat lung. Transplantation (1988) 0.95
"Quilty" revisited: a 10-year perspective. Hum Pathol (1995) 0.95
Cytokine gene expression in rejecting cardiac allografts. Transplantation (1992) 0.95
Role of the liver in inflammation. Nat New Biol (1971) 0.94
Frequency of familial nature of dilated cardiomyopathy and usefulness of cardiac transplantation in this subset. Am J Cardiol (1989) 0.94
Suppressive effect of homologous and heterologous inflammatory exudate on tuberculin sensitivity in the guinea pig. Am Rev Respir Dis (1970) 0.93
Cardiac graft vascular disease. Nonselective involvement of large and small vessels. Transplantation (1993) 0.92
Transvenous biopsy from canine orthotopic heart allografts. Am Heart J (1973) 0.92
Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues. J Clin Invest (1992) 0.91
Correlative study of regional left ventricular histology and contractile function. Am J Cardiol (1977) 0.91
Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation (1996) 0.91
Treatment of rats with monoclonal anti-CD4 induces long-term resistance to streptococcal cell wall-induced arthritis. Eur J Immunol (1992) 0.90
Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model. Transplantation (1981) 0.90
A reappraisal of the structure of normal canine articular cartilage. J Anat (1988) 0.90
Infection of glutaraldehyde-preserved porcine valve heterografts. Am J Cardiol (1979) 0.90
Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo. Transplant Proc (1993) 0.89